 |
 |
|
|
Articles 
Michael A. Steinman, Ralph Gonzales, Jeffrey A. Linder, and C. Seth Landefeld Antibiotic use in ambulatory patients is decreasing in the United States. However, physicians increasingly prescribe expensive, broad-spectrum agents, even when there is little clinical rationale for their use.
Robert C. Read, Chris Cannings, Simone C. Naylor, Janine M. Timms, Ravi Maheswaran, Raymond Borrow, Edward B. Kaczmarski, and Gordon W. Duff Genotype at the interleukin-1 gene locus influences the likelihood of surviving meningococcal infection but does not affect susceptibility to the infection. Increasing age and infection with serogroup C also influence the likelihood of death.
Tomas Berl, Lawrence G. Hunsicker, Julia B. Lewis, Marc A. Pfeffer, Jerome G. Porush, Jean-Lucien Rouleau, Paul L. Drury, Enric Esmatjes, Donald Hricik, Chirag R. Parikh, Itamar Raz, Philippe Vanhille, Thomas B. Wiegmann, Bernard M. Wolfe, Francesco Locatelli, Samuel Z. Goldhaber, Edmund J. Lewis for the Collaborative Study Group* Treatment with irbesartan, amlodipine, or placebo led to the same composite cardiovascular event rate (cardiovascular death, myocardial infarction, congestive heart failure, strokes, and coronary revascularization) in patients with type 2 diabetes and overt nephropathy who also received conventional antihypertensive therapy.
Reviews
Indresh K. Srivastava and Margaret A. Liu This article describes the immunologic rationale, design, and evaluation of gene vaccines for various clinical applications.
Daniel C. Chung and Anil K. Rustgi This review highlights the key features of normal DNA replication and the genetic and biochemical mechanisms that ensure the fidelity of this process. It then shows how mutations in the genes involved in DNA mismatch repair lead to hereditary nonpolyposis colorectal cancer and describes how knowledge of the genetic origins of this disease inform the management of patients who are at increased risk for it.
Perspectives
Michael J. Green and Jeffrey R. Botkin This paper examines the arguments for "genetic exceptionalism" (the idea that genetic tests are unique and therefore justify special consideration for informed consent and privacy) and concludes that the same principles that inform the use of nongenetic tests also apply to genetic tests.
Richard S. Cooper and Bruce M. Psaty The authors suggest how to use currently accepted principles to assess the potential contribution of genomics to medicine and public health. They also speculate about the broader context that makes the rhetoric of the genomics revolution so compelling yet so likely to lead to misinterpretation of its potential impact.
History of Medicine
J.D. Watson and F.H.C. Crick We have reprinted Watson and Crick's original paper from the 25 April 1953 issue of Nature (with permission of the publisher). It repays careful reading for its scientific content; the spare, precise prose; and the careful references to unpublished experimental results, which we now know gave the authors ample cause for confidence in their proposed structure for DNA.
Mahlon B. Hoagland From the mid-1940s to the late 1950s, biological science focused on 1) the nature of the gene and genetic information and 2) the mechanism of protein synthesis. The former was the realm of molecular biologists; the latter attracted the classical biochemists. Although a wide scientific cultural gap separated these two approaches, they were complementary to one another and were destined to merge, unexpectedly and dramatically, 3 years after Watson and Crick published their celebrated paper.
Clinical Guidelines
Vincenza Snow, Kevin B. Weiss, Christel Mottur-Pilson for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians* This article describes the American College of Physicians' guidelines for managing hypertension in patients with type 2 diabetes mellitus. It answers the following questions: 1) What are the benefits of tight blood pressure control in type 2 diabetes? 2) What are appropriate target levels of systolic blood pressure and diastolic blood pressure for patients with type 2 diabetes? and 3) Are certain antihypertensive agents more effective in patients with diabetes?
Sandeep Vijan and Rodney A. Hayward The authors use the accumulated results of research on the effects of blood pressure on the complications of type 2 diabetes to recommend optimal blood pressure goals and preferred antihypertensive drugs. This paper provides the rationale for the American College of Physicians' clinical guidelines and provides an evidence base to guide clinicians in setting hypertension treatment goals and priorities in patients with type 2 diabetes.
Editorials
William N. Kelley What we take for granted in the clinical literature today was just recently considered basic science. As we begin to reap the benefits of the scientific progress achieved over the past 50 years, we must, as a nation, continue to support our basic science and clinical research enterprise and the training of physician-scientists, who are most critical to conducting the necessary translational research. Failing this, we will not fully realize the ultimate promise inherent in Watson and Crick's discovery.
Richard E. Besser In this issue, Steinman and colleagues look at the changing patterns of antimicrobial selection during the 1990s. While overall prescribing declined during the 1990s, use of targeted therapy shifted to use of broader-spectrum agents. Does it matter that broader-spectrum agents are being overused? What is the cost?
Letters Economic Analysis of Influenza Vaccination and Treatment
Duplex Ultrasonography in Temporal Arteritis
Oral Vitamin K for Warfarin-Associated Coagulopathy
Emmet B. Keeffe
Muhyi Al-Sarraf
| |||||||||||||||||||||||||||||||||||||||||||||||||
In this Issue
Articles
Previous Issue